|
[1]Chisari Fv&Ferrari C.Hepatitis B virus immunopathology[J].Springer Semin Immunopathol, 1995, 17∶261.
|
|
[2]Ando K, Guidotti LG, Wirth S, et al.Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo[J].J Immunol, 1994, 152∶3245.
|
|
[3]AndoK , MoriyamaT , GuidottiLG , etal.Mechanismsofclass Ire strictedimmunopathology [J] .JExpMed , 1993, 178∶15 41.
|
|
[4]GilelsPN , FeyG , ChisariFV , Tumornecrosisfactor alphanegtivelyregulateshepatitisBvirusgeneexpressionintransgenicmice[J] .JVirol, 1992 , 6 6∶3995 .
|
|
[5]Guidotti LG, Ando K, Hobbs MV, et al.Cytotoxic T lymphocyte inhibits Bvirus gene expression by a noncytolytic mechanisim in transgenic mice[J].PNAS USA, 1993, 91∶3764.
|
|
[][6 ]GuidotteLG , GuilhotS , ChisariFV , Interlukin 2andinterferon al pha/betadownregulatehepatitisBvirusgeneexpressioninvivobytumornecrosisfactor dependentandI independentpathways[J] .JVirol, 1994, 6 8∶12 6 5 .
|
|
[7]GuilhotS , GuidotteLG , ChisariFV .Interlukin 2downregulateshep atitisBvirusgeneexpressionintransgenicmicebyapost transcrip tionalmechanism[J] .JVirol, 1993, 6 7∶7444 .
|
|
[8]Guidotti LG, Borrow P, Hobbs MV, et al.Viral cross talk:intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver[J].PNAS USA, 1996, 94∶4589.
|
|
[9]Cavanaugh VJ, Guidotti LG, Chisari FV, et al.Inhibition of heaptitis B virus replication during adenovirus and cytomegalovirus infection in transgenic mice[J].J.Virol, 1998, 72∶2630.
|
|
[10]Guidotti LG, Rochford R, Chung J, et al.Viral clearance without destruction of infected cells during acute HBV infection[J].Science, 1999, 284∶825.
|
|
[11]AkbarSMF&OnijiM .HepatitisBvirus (HBV) infectionmice :asaninvestigativetooltostudyimmunopathologyduringHBVinfec tion [J] .IntJExpPath , 1998, 79∶2 79.
|
|
[12]Guidotti LG, lshikawa T, Hobbs MW, et al.Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes[J].Immunity, 1996, 4∶25.
|
|
[13]AndreoneP , CursaroC , GramenziA , etal.Arandomizedcontrolledtrialofthymosin α 1versusinterferonalfainpatientswithhepatitisBeantigenantibodyandhepatitisBvirusDNA positivechronichep atitisB[J] .Hepatol, 1996 , 2 4∶774.
|
|
[14]De Clercq E.Perspectives for the treatment of hepatitis B virus infections[J].Int J Antimicrob Agents, 1999, 12 (2) ∶81.
|
|
[15]Heijtink RA, Paulij W, van Roosmalen M, et al.Characteristics of the early phase of chronicity in acute hepatitis B infection[J].J Med Virol, 1999, 57 (4) ∶331.
|
PDF下载 ( 92 KB)
本文二维码
下载:
